東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cognitive enhancement

Kantak, Kathleen M.

FindBook

Google Book

Amazon

博客來

Cognitive enhancement

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cognitive enhancement/ edited by Kathleen M. Kantak, Joseph G. Wettstein.
其他作者:	Kantak, Kathleen M.
出版者:	Cham :Springer International Publishing : : 2015.,
面頁冊數:	viii, 470 p. :ill., digital ;24 cm.
內容註:	Preface -- Part 1. Basic Approaches and Perspectives -- Part 2. Cognitive Domains for Pharmacological Intervention: Implications for Neuropsychiatric and Neurological Illnesses -- Part 3. Developmental Disorders, Emerging Technologies and Ethical Considerations.
Contained By:	Springer eBooks
標題:	Nootropic agents - Development. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-16522-6
ISBN:	9783319165226 (electronic bk.)

Cognitive enhancement
Cognitive enhancement[electronic resource] /edited by Kathleen M. Kantak, Joseph G. Wettstein. - Cham :Springer International Publishing :2015. - viii, 470 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2280171-2004 ;. - Handbook of experimental pharmacology ;208..

Preface -- Part 1. Basic Approaches and Perspectives -- Part 2. Cognitive Domains for Pharmacological Intervention: Implications for Neuropsychiatric and Neurological Illnesses -- Part 3. Developmental Disorders, Emerging Technologies and Ethical Considerations.

This book highlights the behavioral and neurobiological issues relevant for drug development, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacological approaches to cognitive enhancement.

ISBN: 9783319165226 (electronic bk.)

Standard No.: 10.1007/978-3-319-16522-6doiSubjects--Topical Terms:

2152939
Nootropic agents
--Development.

LC Class. No.: RM334

Dewey Class. No.: 615.78

Cognitive enhancement
LDR:01610nmm a2200325 a 4500 001 2006160
003 DE-He213
005 20151203132156.0
006 m d
007 cr nn 008maaau
008 160114s2015 gw s 0 eng d
020 $a 9783319165226 (electronic bk.)
020 $a 9783319165219 (paper)
024 7 $a 10.1007/978-3-319-16522-6 $2 doi
035 $a 978-3-319-16522-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RM334
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 615.78 $2 23
090 $a RM334 $b .C676 2015
245 0 0 $a Cognitive enhancement $h [electronic resource] / $c edited by Kathleen M. Kantak, Joseph G. Wettstein.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a viii, 470 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.228
505 0 $a Preface -- Part 1. Basic Approaches and Perspectives -- Part 2. Cognitive Domains for Pharmacological Intervention: Implications for Neuropsychiatric and Neurological Illnesses -- Part 3. Developmental Disorders, Emerging Technologies and Ethical Considerations.
520 $a This book highlights the behavioral and neurobiological issues relevant for drug development, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacological approaches to cognitive enhancement.
650 0 $a Nootropic agents $x Development. $3 2152939
650 0 $a Cognitive therapy. $3 524357
650 0 $a Cognitive neuroscience. $3 532901
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Pharmacology/Toxicology. $3 890953
650 2 4 $a Neurosciences. $3 588700
650 2 4 $a Neurology. $3 588698
650 2 4 $a Psychopharmacology. $3 568143
700 1 $a Kantak, Kathleen M. $3 2152937
700 1 $a Wettstein, Joseph G. $3 2152938
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 1567347
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-16522-6
950 $a Biomedical and Life Sciences (Springer-11642)